Catalyst Wire Dossier Catalyst Wire Dossier

Relievion

· Neurolief Ltd.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Relievion, covering 2018-03-29 to 2018-03-29. Get the full timeline:

Most recent: Clinical Trial Update: A Randomized, Double-blind Clinical Investigation to Evaluate the Use of the Relievion™ Device in Treating Migraine. [NA]

See pricing